Researchers at Imperial College London have developed two novel modifications of bacteriophages to significantly improve their efficacy as vectors for targeted gene therapy, and exploit their advantages over eukaryotic viral vectors.
Suite of microRNAs for predicting cervical shortening and preterm birth that can be measured from blood samples taken in early pregnancy (from gestation week 12 onwards).
Novel truncated fragments of von Willebrand factor (VWF) engineered by a team at Imperial College London.
A selective and sensitive approach to detect multiple proteins from complex biological samples.
Enables the production of lightweight but tough and damage tolerant structures
Over 3x energy saved vs standard wireless IoT sensor implementations.
Low Weight Portable Wireless Power Transfer
Smart contracts that lawyers can program
ENGINI is a next generation neural implant technology for brain machine interfaces (BMIs) applicable to both central and peripheral nervous system
Using smartphone technology to assess cardiac health